p = 0.0004). For patients with mainly somatic illness beliefs (23 % of the sample), we did not find a trade-off between costs and outcome. Conclusion For the majority of patients, we found a trade-off between costs and health outcome, thus, it seems advisable to carefully monitor outcome parameters when applying cost containment measures.
Key Points for Decision Makers
• Our findings suggest that costs had a significant positive effect on outcome in patients without or with only minor somatic illness beliefs (77 % of the sample), i.e. for this patient group, a trade-off between treatment costs and quality of care was identified.
• More research is needed to confirm our results.
However, the results of this study strongly suggest careful monitoring of outcome parameters when applying cost containment measures.
Introduction
Various Western countries have recently replaced or are in the process of replacing reimbursement systems in inpatient mental health that are considered inefficient (e.g. costbased systems) with efficiency-oriented systems based on diagnosis-related groups (DRGs) [1] [2] [3] . The change in reimbursement systems may increase pressure for providers to reduce treatment costs. If providers cut costs by withholding necessary services in the treatment of patients, negative effects on quality of care are possible [4, 5] . For decision and policy makers in healthcare, it is important to know the trade-off between treatment costs and quality of care to avoid unintended effects on quality of care that may result from reductions in resource utilization [6] [7] [8] .
Various studies have analyzed the trade-off between costs and outcomes, although, to our knowledge, none so far have done so for mental health. Earlier studies were conducted at the hospital level, using aggregate measures for costs and outcomes [6] [7] [8] . More recent studies have investigated the association between costs and health outcomes for selected conditions treated in hospitals: studies by Schreyoegg and Stargardt [4] , Stargardt et al. [9] , Romley et al. [10] and Stukel et al. [11] found a positive association between costs and health outcomes, Jha et al. [12] and Lagu et al. [13] found no association, and in a study by Chen et al. [14] , the direction of the relationship between costs and health outcome seemed to depend on the condition that was analysed.
As this was the first study to analyze the cost-outcome relationship in mental health, we analysed the trade-off between costs and treatment quality for inpatients with somatoform pain disorder. Somatoform pain disorder is an illness characterized by predominant complaints of persistent, severe and distressing pain, which cannot be explained adequately by a physiological process or a physical disorder [15] . Maintaining a high quality of care of inpatient psychosomatic treatment is essential. Somatoform pain disorder is one of the most common psychosocial disorders, with a 12-month prevalence of around 8-12 % in the general population [16, 17] . Patients in ambulatory settings are generally not treated by psychotherapists or psychiatrists, but instead receive conservative medical treatment, which generally shows little treatment effect [18, 19] . Patients who have not been effectively treated tend to continuously seek reassurance from various physicians that their symptoms are not related to an underlying organic pathology, causing high unnecessary costs for the healthcare system [18, 20, 21] .
Methods

Study Design and Data Collection
We expected the outcome quality of care to be a function of treatment costs, standard patient characteristics, sociodemographic variables, pain-related variables and co-morbidities [22, 23] . Patients hospitalized at the Department of Psychosomatic Medicine at Charité Universitaetsmedizin (Berlin, Germany) for at least 2 days between January 2006 and June 2010 with a main diagnosis of 'persistent somatoform pain disorder', with International Classification of Diseases (ICD-10) codes F45.4, F45.40, F45.41, were followed until discharge. The Short Form Health Survey-8 (SF-8) was administered to the patients at admission and discharge. Data were only collected if the patients had selfadministered the SF-8 within ± 3 days of their admission and discharge dates. All data were collected at or obtained from Charité Universitaetsmedizin. All socio-demographic and pain-related variables were formed according to information given by the patient at admission, which was retrieved from the doctor's letter. Inpatient costs were calculated from the hospital's perspective. To collect information on labour input for procedures, therapy units etc. by physicians, therapists or dietitians, questionnaires were used.
Measurement of Costs
We calculated costs for services delivered directly to the patient by physicians, nurses, dietitians or therapists, and for services requested by the department, such as imaging and laboratory services, on the basis of the actual consumption of resources by each patient in the sample (bottom-up micro-costing). We used gross costing to calculate costs for non-patient-related time by physicians, therapists and dietitians, and costs for medical supplies, medication and overheads [24] . The year of valuation for cost calculation was 2008 (with no inflation adjustment), apart from costs calculated by the cost accounting department for services consumed by the patient, i.e. costs for physiotherapists and services requested by the department (with valuations based on the year of service provision).
We calculated labour costs for physicians (residents and senior physicians), dietitians and psychotherapists on the basis of the employer gross p.a. (i.e. the salary plus the employer's social security contributions) and working time hours including overtime as estimated by medical staff. We distinguished between activities by medical staff during which time was spent directly with/for the patient (patientrelated activities) and more general activities that could not be allocated to a specific patient (non-patient-related activities) [see Table 1 ].
Patient-related activities were (i) activities that occurred once per hospital stay per patient; (ii) activities that occurred depending on the patient's length of stay; or (iii) activities that related to therapy units consumed by each patient according to need (see Table 1 ). Costs for patientrelated activities were calculated according to the actual resource use in minutes by each patient.
To calculate costs for non-patient-related activities, medical staff estimated the percentage of time not spent directly with/for patients, e.g. 36 % as estimated by physicians (see Table 1 ). Consequently, 36 % of the employer gross for physicians was allocated to each case on the basis of the total number of cases in the department per year. Costs for the head physician were allocated on the basis of the number of cases in the department in 2008, since nonpatient-related activities were by and large the priority. Costs for music and art group therapy units were evaluated at the wage rate per hour of music and art therapists. For all therapies, a capacity utilization of 75 % of the maximum group size, i.e. the maximum number of patients accepted in a therapy unit, was assumed. Costs for requested services, such as imaging and laboratory services, and costs for physiotherapists were calculated as consumed by each patient and provided by the accounting department (the year of valuation was based on the year of service provision).
For nursing care, patients were assigned to one of nine nursing categories each day, according to the patients' needs. The German Directive on Nursing Care assumes a different amount of nursing time spent for each category. Nursing costs were calculated by dividing the total nursing costs by the total nursing minutes at the department level.
Costs for medical supplies and drugs were allocated per case. Overhead costs for medical infrastructure (e.g. maintenance of medical-technical equipment) were allocated per case on the basis of the total number of cases treated in the department. The overhead costs for nonmedical infrastructure (e.g. maintenance of property, energy) were allocated per bed day on the basis of the total number of inpatient days in the department, assuming a strong relationship between overhead costs for non-medical infrastructure and patients' length of hospital stay.
Measurement of Quality of Care
Quality of care can be assessed on the basis of structure, process and outcome [25] . In this context, outcome quality describes changes that a patient experiences and is considered the ultimate validator of effectiveness and quality of care [26] . Traditionally, outcome measures such as morbidity or mortality have been used to evaluate treatment outcomes; however, in the treatment of chronic diseases (especially mental diseases), traditional outcome measures may have limited meaning. Patient-based outcomes such as health status or quality of life have gained in importance when evaluating treatment outcomes in chronically ill populations [27] [28] [29] [30] . Health-related quality of life refers to aspects of patients' physical and mental functioning that are most directly influenced by disease and intervention [31] . Considering that our patient sample was affected by a psychosocial disorder, we used a patient-based outcome-mental health-related quality of life-as a qualitative indicator [30, 32] .
For measurement of mental health-related quality of life, we used the SF-8 Health Survey, which is a brief, reliable and well-validated version of the SF-36 [33, 34] . The SF-8 is a responsive instrument able to capture changes in patients' health-related quality of life over time [31, 33, 35] and has proven successful in outcomes research applications [33, 35, 36] . SF Health Surveys are the most widely used patient-based outcome measures worldwide [34] . Their scales/component summary scores are comparable with each other (SF-8, SF-12, SF-36), allowing comparisons across surveys [33] .
According to instrument guidelines by Ware et al. [33] , a norm-based scoring method was used to produce a mental component summary (MCS-8) score for each patient, reflecting the overall functioning of the mental health of patients. The MCS-8 is a continuous variable and is scored with a value of 50 and a standard deviation of 10 indicating the average value in the general US population [33] . We used the MCS-8 to assess each patient's change in overall mental health incurred over the treatment period. Higher MCS-8 scores indicate better self-reported health. For each patient, we subtracted the MCS-8 score at admission from the MCS-8 score measured at discharge to form the outcome variable DMCS 8. Negative values of DMCS 8 indicate deterioration, and positive values indicate improvement of overall functioning of mental health.
Statistical Analysis
It was the objective of this study to analyse the effect of treatment costs on quality of care. We hypothesized that DMCS 8 was a function of treatment costs, the interaction between treatment costs and somatic attribution (explained in Sect. 2.5), patient characteristics, socio-demographic variables, co-morbidities, and pain-related variables, as well as the interaction between covariates:
where u i is the unobserved disturbance. Standard ordinary least squares (OLS) regression in the generalized linear model (GLM) procedure from Statistical Analysis Software (SAS) version 9.2 was used for the analysis. More information on the following subjects is provided in the Electronic Supplementary Material (see Online Resource 1, Sections A and B): (i) checking of model assumptions, including a detailed description of variance inflation factor statistics (VIF statistics) used to evaluate multicollinearity in the model; (ii) missing values; (iii) outliers; and (iv) information on how changes in the outcome variable were evaluated using Cohen's d and the minimal clinical important difference (MCID).
Control Variables
We included various covariates in the regression model. For more information on covariate selection, please see
Online Resource 1, Section C. Furthermore, we included interactions between covariates. For detailed information on the process of effect selection, please see Online Resource 1, Section D. The interaction between 'number of pain sites at admission' and 'duration of pain in years since pain onset' was included in the final model.
Test for Endogeneity
We hypothesized that treatment costs would have an effect on the patient outcome DMCS 8; however, we could not exclude the possibility that the patient's health status during treatment had an effect on the medical staff's decisions on resource utilization and, thus, treatment costs (reverse causality). In such a case, costs would be assumed to be endogenous. Reverse causality implies violation of independence of errors [37] . To test for independence of errors, we conducted the omitted variable version of the Hausman Test [38] . For details on the conduct of the Hausman Test, please see Online Resource 1, Section E.
Sensitivity Analysis
Regarding the calculation of costs, we ran a sensitivity analysis in which we allocated the percentage of the employer gross for non-patient-related activities on the basis of the patient's length of stay instead of on the total number of cases treated by the department in 2008 (for residents, senior physicians and the chief physician, as well as psychotherapists and dietitians).
To further investigate the relationship between costs and outcomes, we ran four separate regression analyses for cost components-each model containing one of the following cost components: total costs for physicians per case; total costs for nursing per case; total costs of care by therapists and dietitians per case (including costs for psychotherapists, physiotherapists, music and art therapists, dietitians); and total costs for services requested by the department per case (imaging, laboratory, etc.).
Results
Baseline Characteristics
We report on a sample of 101 patients diagnosed with somatoform pain disorder. Eighty-two patients were female (81.2 %) and 19 were male (18.8 %), aged between 18 and 80 years (mean age 49.6 years; standard deviation [SD] 14.2). The mean of the variable 'length of stay' (LOS) was 17.7 days (SD 8.9), and the minimum and maximum LOS were 7 and 62 days, respectively. For information on socio-demographic variables, pain-related variables and co-morbidities, please see Table 2 .
Inpatient Costs of Somatoform Pain Disorder
As Table 3 
Results of the Empirical Model
Regression results are depicted in Table 4 . We interpreted the effect of the total costs per case on DMCS 8 conditional on whether patients attributed their pain mainly to a somatic cause or not. Patients without somatic attribution improved 0.4 points in outcome after every 100 € increase in total costs per case (F 1,77 = 13.836, t(77) = 3.72, p = 0.0004), while an increase in total costs per case did not significantly improve the outcome of patients with somatic attribution (F 1,77 = 0.5, t(77) = 0.71, p = 0.4810). This finding is also displayed in Fig. 1 . The significant interaction effect between total costs per case and somatic attribution indicated that the variable total costs per case had a significantly different effect on the outcome depending on the patient group (F 1,77 = 4.14, t(77) = -2.03, p = 0.0454). For every 100 € increase in treatment costs, improvement in overall functioning of mental health was 0.3 points higher for patients without somatic attribution than for patients with somatic attribution.
The adjusted mean outcome for patients with somatic attribution indicated an improvement by 5.44 points, assuming mean treatment costs of 3,242 € (Fig. 1) , thus, an MCID that was perceptible by the patient could be assumed. For this patient group, the effect size according to Cohen's d was 0.28 [39] , indicating a small to moderate change. The adjusted mean outcome for patients without somatic attribution, given mean total costs, was -0.18 ( Fig. 1) . In terms of the effect size according to Cohen's d, the value calculated for this patient group was -0.05, indicating no change [39] . The value of -0.18 lies far below the MCID of circa 3 points for SF Health Surveys [40, 41] . The prediction based on our model suggests that an additional resource input of 880 € for this patient group would reach an MCID of 3 points.
Covariates
For the effects of covariates on the outcome variable, please see Table 4 . Given the small numbers of patients in the categories 'pursuing education' and 'widowed', the results have to be interpreted with caution. Patients with school education of 12-13 years had a positive change in MCS-8 of ?8.8 points, which was 9 points higher than that of patients with school education of B10 years (p = 0.0350), and patients with school education of [13 years had a positive change in MCS-8 of ?5.6 points, which was 5.9 points higher (p = 0.0177) than that of patients with school education of B10 years. The interaction between 'number of pain sites' and 'duration of pain in years since onset' (p = 0.0024) indicated that the relationship between outcome and 'duration of pain in years' significantly relied upon 'number of pain sites' (or vice versa).
Results of Sensitivity Analysis
We ran a sensitivity analysis in which we apportioned costs for non-patient-related activities by physicians, psychotherapists and dietitians on the basis of the patient's length of stay. The interpretation of the results of the main regression analysis did not change ('total costs per case': coeff. = 0.0031, p = 0.0005; 'somatic attribution': coeff. = 5.611, p = 0.0143; 'total costs per case*somatic attribution': coeff. = -0.00248, p = 0.0453).
Model 1, which included total costs for physicians per case, revealed that a 100 € increase in total costs for physicians per case was associated with a significant increase of 6.7 points in DMCS 8 for patients without somatic attribution (F 1,77 = 5.72, t(77) = 2.39, p = 0.0192); however, there was no significant effect for patients with somatic attribution (F 1,77 = 0.09, t(77) = 0.30, p = 0.7681). Model 2, which included total costs for nursing per case, indicated that for patients without somatic attribution, a 100 € increase in total costs for nursing per case was associated with a significant increase in DMCS 8 by 0.9 points (F 1,77 = 10.90, t(77) = 3.30, p = 0.0015); there was no significant effect for patients with somatic attribution (F 1,77 = 0.41, t(77) = 0.64, p = 0.5250). Model 3, which included total costs for services requested by the department per case, revealed that for patients without somatic attribution, a 100 € increase in total costs for requested services per case was associated with a significant increase of 0.8 points in DMCS 8 (F 1,77 = 10.57, t(77) = 3.25, p = 0.0017); there was no significant effect for patients with somatic attribution (F 1,77 = 0.05, t(77) = -0.22, p = 0.8252). In model 4, the total costs of care by therapists and dietitians per case did not significantly affect the outcomes of patients without somatic 
Discussion
Our results suggest that total costs per case were linked in a positive relationship with the quality of care in patients without somatic attribution (77 % of the sample). The trade-off between costs and health outcomes also suggests that potential reductions in treatment resources, as consequences of economic pressures in inpatient mental health, would likely lead to further worsening of health outcomes in this patient group. Conversely, the total costs per case did not significantly impact the outcome in patients with somatic attribution (23 % of the sample). In patients without somatic attribution, the overall functioning of mental health improved by 0.4 points following a 100 € increase in total costs per case. However, it is striking that the adjusted mean change in mental health outcome, assuming mean total costs per case for a patient in this group, was merely -0.18 points. The prediction based on our model suggests an additional resource input of 880 € to reach the recommended MCID for SF Health Survey of ca. 3 points. However, when drawing practical implications from this result, it has to be considered that this result may vary depending on model specification, the sample size (which in our study was relatively small for patients with somatic attribution) and the MCID used. It is possible that the MCID for the diagnosis of somatoform pain disorder deviates somewhat from the suggested general point value of 3 points. However, there is no literature suggesting an MCID for SF Health Surveys for pain patients undergoing psychosomatic therapy.
The results of sensitivity analysis confirmed the results from the main model. Total costs for physicians per case, total costs for nursing per case, and total costs for services requested by the department per case had a significant positive effect on the outcome in patients without somatic attribution. However, the total costs of care by therapists and dietitians per case did not have a significant effect on the outcome for either patient group. Patients without somatic attribution seemed to benefit particularly from care by physicians and nursing staff, as well as from laboratory test results, imaging, etc. The results on costs for nursing suggested that patient outcome improved with increasing LOS and/or nursing intensity. Diagnostic examinations seemed to have a positive effect on outcome, indicating that (potentially) dysfunctional beliefs in severe organic diseases may have been successfully discouraged. It is somewhat surprising that total costs of care by therapists and dietitians per case were not found to be significant in improving treatment outcome in our study, since studies have shown positive effects of psychotherapy on treatment outcome of psychosomatic inpatients in general [42, 43] , as well as that of patients with somatoform disorders [44, 45] . The total costs of care by therapists and dietitians per case comprised costs for four different types of therapies (services by dietitians, art and music therapists, departmental psychologists and physiotherapists), and it may be that these therapies had differing effects on the outcome, thus precluding a clear effect.
Patients with somatic attribution showed a positive change in overall functioning of mental health, which, however, did not seem to depend on treatment costs. This patient group was less likely to present with psychosocial difficulties than patients whose illness was assumed to have psychosocial/mixed causes [46] [47] [48] . Thus, it is possible that these patients rather requested less costly mono-causal therapies according to their illness concept, focussing on standard medical treatments and somatic remedies-and indeed felt some alleviation, resulting in a distinct positive change in the overall functioning of their mental health [49, 50] .
Our results are in line with those of various studies that also found a positive relationship between costs and health outcomes for specific conditions treated in hospital [4, 10, 11] . Stukel et al. [11] found a positive association between hospital spending and health outcomes for the conditions acute myocardial infarction (AMI), congestive heart failure (CHF), hip fracture and colon cancer with surgical resection. Similarly, Romley et al. [10] found a positive relationship between hospital spending and health outcome across the conditions AMI, CHF, acute stroke, gastrointestinal haemorrhage, hip fracture and pneumonia. Schreyoegg and Stargardt [4] focussed on AMI and found a positive association between hospital costs and health outcome. However, comparability to the aforementioned studies is limited, since they used mortality as an outcome, focussed on conditions of acute care and used different statistical methods.
Our study had a number of strengths. First, it was the first study to have analysed the trade-off between costs and health outcome in mental healthcare. Second, the focus on a specific condition, i.e. somatoform pain disorder (compared with studies that have used aggregate measures for costs and outcomes), enabled us to give an empirically derived estimation of the trade-off. This knowledge may help decision makers and clinicians to manage resource input differently to optimize outcomes for both patient groups. Third, we also provided detailed data on actual inpatient costs from the hospital's perspective, which-so far-has not been available for patients with somatoform pain disorder. Finally, given the standardization applied to our SF-8 scores, our results can be directly compared with SF-12 or SF-36 scores across conditions.
Our study also had various limitations. One major concern when using patient-based outcomes as indicators Variations in outcome measures may indeed be due to service delivery but may also be due to differences between patients or random variation [22, 32, 51] . To mitigate the possibility that variations in outcome are due to differences between patients, we carefully risk-adjusted for confounding factors such as disease severity, co-morbidities and sociodemographic variables [32, 51] . Random variation, which may mask real differences in outcome or may make spurious differences appear, depends on the sample size and the frequency with which the outcome occurs. However, as the chosen outcome applied to the whole sample, we evaluated our sample size as being sufficiently large. Last, we used data from one hospital, which raises the question of generalizability beyond Charité Universitaetsmedizin. The hospital is a major university hospital, encompassing over 100 clinics. Overhead costs seemed relatively low when looking at the cost numbers in this study-this may have been due to economies of scale resulting from pooled purchasing, common infrastructures and management, etc. Thus, the hospital we studied may be more efficient than other hospitals. Furthermore, it is not clear to what extent the patient structure is representative of other German hospitals. Charité, as a specialized university hospital, is likely to treat more severe cases than other psychosomatic pain clinics in Germany. Treatment patterns, however, can be assumed to be similar for psychosomatic pain clinics in Germany, since treatment guidelines exist and multimodal psychosomatic treatment is generally used for treatment (22-23 h of interventions per week [52] ). For the reasons mentioned above, we cannot exclude the possibility that the cost and outcome relationship varies across hospitals, according to patient characteristics, hospital characteristics and each hospital's efficiency.
Conclusion
For patients without or with only minor somatic illness beliefs (77 % of the sample), we identified a trade-off between costs and quality of care. Outcome parameters should be closely monitored when introducing efficiencyoriented reimbursement in mental health, which is currently planned in several countries. However, as this is the first study on the cost-outcome relationship in mental health, additional studies are needed to examine the costoutcome relationship for other mental health conditions and other countries, in order to see whether our results are consistent. 
